Korean vaccine developer and manufacturer with global partnerships
SK bioscience, IDT Biologika and Vaxxas Selected for Next-Generation Influenza Vaccine Development Financed by the European Union
SK Bioscience, with partners IDT Biologika and Vaxxas, was selected for an EU-financed project to develop a next-generation influenza vaccine.
当该公司有新信号时，立即收到通知。
